Login / Signup

Cinacalcet reverses short QT interval in Familial Hypocalciuric Hypercalcemia type 1.

Thomas CunyPauline RomanetMichelle GoldsworthyCarole GuérinMarie WilkinPhilippe RocheFrédéric A SebagLynn E van SummerenMark StevensonSarah A HowlesJean Claude DeharoRajesh V ThakkerDavid Taïeb
Published in: The Journal of clinical endocrinology and metabolism (2023)
Our results indicate that FHH-1 patients should be assessed for a short QT interval, and a cinacalcet test used to select patients who are likely to benefit from this treatment.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • patient reported outcomes
  • drug induced